Preferred Pharmaceuticals recalls Motrin Ibuprofen Tablets due to impurities
Preferred Pharmaceuticals recalls 30-tablet Motrin Ibuprofen 400mg bottles made by Dr. Reddy's Laboratories with potential impurities. Consumers should check lot numbers and contact the company for details.
Recall notice
Failed Impurities/Degradation Specifications - at 18-month Stability testing
Contact the company
What happened, in plain English
Preferred Pharmaceuticals is recalling Motrin Ibuprofen 400mg tablets that may have impurities. This could pose a risk to health if taken as directed, though the specific danger isn't detailed in the recall. Read more at govinfonow.com/recall/32567-preferred-pharmaceuticals-recalls-motrin-ibuprofen-tablets-due-to-impurities.
Source Summary by GovInfoNow · govinfonow.com/recall/32567-preferred-pharmaceuticals-recalls-motrin-ibuprofen-tablets-due-to-impurities · Updated August 18, 2026 · FDA enforcement record: FDA #D-0647-2024
Cite this page
“Preferred Pharmaceuticals recalls Motrin Ibuprofen Tablets due to impurities.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/32567-preferred-pharmaceuticals-recalls-motrin-ibuprofen-tablets-due-to-impurities. Based on FDA recall #D-0647-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0647-2024%22&limit=1).
Why it’s dangerous
The tablets failed stability testing at 18 months, suggesting possible impurities that could affect safety. However, the recall doesn't specify how these impurities might cause harm or what the exact risk level is.
Who’s affected
People who own or use the recalled Motrin Ibuprofen tablets made by Dr. Reddy's Laboratories. Those with chronic pain conditions or frequent users may be at higher risk.
How to tell if you have this one
Check for the lot numbers B0223H (expires 5/31/2026) or C3023H (expires 9/30/2026) on the bottle. The product is a 30-tablet Motrin Ibuprofen 400mg bottle manufactured by Dr. Reddy's Laboratories.
- Brand
Preferred Pharmaceuticals- Category
Drug
What to do — step by step
Check Product Details
Look for the lot numbers B0223H or C3023H on the bottle label.
Where it went and when
Where it was distributed
Distributed in California and Nevada.
FDA distribution: “CA and NV” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: California, Nevada.
Recall timeline
FDA published this recall 27 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Preferred Pharmaceuticals recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0647-2024 (August 8, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0647-2024 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.